Viewing 0 reply threads
  • Author
    • #18340

      It’s a new year of groundbreaking research for the FA Community! Here are key highlights on Friedreich’s Ataxia Research Alliance (FARA) Research Pipeline:

      -The GeneTAC clinical trial to start in the first half of this year
      -AavantiBio’s gene therapy trial to start by the end of the year -Reata’s
      -Omaveloxolone will be going up for FDA approval the first quarter of this year

      None of this would be possible without participation from FA patients. The faster we enroll in clinical studies and trials, the faster they find a treatment and/or cure.

Viewing 0 reply threads
  • You must be logged in to reply to this topic.

©2022 KLEO Template a premium and multipurpose theme from Seventh Queen


We're not around right now. But you can send us an email and we'll get back to you, asap.


Log in with your credentials


Forgot your details?

Create Account